Imaging High-Risk Atherothrombosis Using a Novel Fibrin-Binding Positron Emission Tomography Probe.
Imaging High-Risk Atherothrombosis Using a Novel Fibrin-Binding Positron Emission Tomography Probe.
复制标题
DOI:
10.1161/strokeaha.121.035638
复制
发表时间:
2022-03
期刊:
影响因子:
8.3
通讯作者:
Ay I
中科院分区:
文献类型:
--
作者:
Izquierdo-Garcia D;Diyabalanage H;Ramsay IA;Rotile NJ;Mauskapf A;Choi JK;Witzel T;Humblet V;Jaffer FA;Brownell AL;Tawakol A;Catana C;Conrad MF;Caravan P;Ay I
High-risk atherosclerosis is an underlying etiology in cardiovascular events, yet identifying the specific patient population at immediate risk is still challenging. Here, we used a rabbit model of atherosclerotic plaque rupture and human carotid endarterectomy specimens to describe the potential of molecular fibrin imaging as a tool to identify thrombotic plaques. Atherosclerotic plaques in rabbits were induced using a high-cholesterol diet and aortic balloon injury (N=13). Pharmacological triggering was used in a group of rabbits (n=9) to induce plaque disruption. Animals were grouped into thrombotic and non-thrombotic plaque groups based on gross pathology (gold standard). All animals were injected with a novel fibrin-specific probe 68Ga-CM246 followed by PET/MR imaging 90 minutes later. 68Ga-CM246 was quantified on the PET images using tissue-to-background (back muscle) ratios (TBR) and standardized uptake value (SUV). Both TBR and SUV were significantly higher in the thrombotic vs. non-thrombotic group (p<0.05). Ex vivo PET and autoradiography of the abdominal aorta correlated positively with in vivo PET measurements. Plaque disruption identified by 68Ga-CM246 PET agreed with gross pathology assessment (85%). In ex vivo surgical specimens obtained from patients undergoing elective carotid endarterectomy (N=12), 68Ga-CM246 showed significantly higher binding to carotid plaques compared to a D-cysteine non-binding control probe. We demonstrated that molecular fibrin PET imaging using 68Ga-CM246 could be a useful tool to diagnose experimental and clinical atherothrombosis. Based on our initial results using human carotid plaque specimens, in vivo molecular imaging studies are warranted to test 68Ga-CM246 PET as a tool to stratify risk in atherosclerotic patients.
影响因子:
0.9
作者:
Ciesienski, Katie L;Caravan, Peter
通讯作者:
Caravan, Peter
影响因子:
15
作者:
Uppal, Ritika;Ciesienski, Kate L.;Chonde, Daniel B.;Loving, Galen S.;Caravan, Peter
通讯作者:
Caravan, Peter